Prevention of clinical and subclinical rubella infection. Efficacy of three HPV-77 derivative vaccines.
D000906:Antibodies / Q000032:analysis; D002648:Child; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks; D006801:Humans; D008297:Male; D008722:Methods; D010614:Pharynx / Q000382:microbiology; D010919:Placebos; D012409:Rubella / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D012411:Rubella Vaccine; D012412:Rubella virus / Q000302:isolation & purification; D013624:Taiwan; D013997:Time Factors; D014611:Vaccination; D014765:Viral Vaccines
D000906:Antibodies; D010919:Placebos; D012411:Rubella Vaccine; D014765:Viral Vaccines